Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | SARS-CoV-2 | Research

Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study

Authors: Anthony Zhenhuan Zhang, Eva A. Enns

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

In January 2020, an outbreak of atypical pneumonia caused by a novel coronavirus, SARS-CoV-2, was reported in Wuhan, China. On Jan 23, 2020, the Chinese government instituted mitigation strategies to control spread. Most modeling studies have focused on projecting epidemiological outcomes throughout the pandemic. However, the impact and optimal timing of different mitigation approaches have not been well-studied.

Methods

We developed a mathematical model reflecting SARS-CoV-2 transmission dynamics in an age-stratified population. The model simulates health and economic outcomes from Dec 1, 2019 through Mar 31, 2020 for cities including Wuhan, Chongqing, Beijing, and Shanghai in China. We considered differences in timing and duration of three mitigation strategies in the early phase of the epidemic: city-wide quarantine on Wuhan, travel history screening and isolation of travelers from Wuhan to other Chinese cities, and general social distancing.

Results

Our model estimated that implementing all three mitigation strategies one week earlier would have averted 35% of deaths in Wuhan (50% in other cities) with a 7% increase in economic impacts (16-18% in other cities). One week’s delay in mitigation strategy initiation was estimated to decrease economic cost by the same amount, but with 35% more deaths in Wuhan and more than 80% more deaths in the other cities. Of the three mitigation approaches, infections and deaths increased most rapidly if initiation of social distancing was delayed. Furthermore, social distancing of working-age adults was most critical to reducing COVID-19 outcomes versus social distancing among children and/or the elderly.

Conclusions

Optimizing the timing of epidemic mitigation strategies is paramount and involves weighing trade-offs between preventing infections and deaths and incurring immense economic impacts. City-wide quarantine was not as effective as city-wide social distancing due to its much higher daily cost than social distancing. Under typical economic evaluation standards, the optimal timing for the full set of control measures would have been much later than Jan 23, 2020 (status quo).
Appendix
Available only for authorised users
Literature
7.
go back to reference Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020; 395(10225):689–97.CrossRef Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020; 395(10225):689–97.CrossRef
8.
go back to reference Leung K, Wu JT, Liu D, Leung GM. First-wave covid-19 transmissibility and severity in china outside hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet. 2020; 395(10233):1382–93.CrossRef Leung K, Wu JT, Liu D, Leung GM. First-wave covid-19 transmissibility and severity in china outside hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet. 2020; 395(10233):1382–93.CrossRef
9.
go back to reference Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, Flasche S, Clifford S, Pearson CA, Munday JD, et al.The effect of control strategies to reduce social mixing on outcomes of the covid-19 epidemic in wuhan, china: a modelling study. Lancet Public Health. 2020; 5(5):e261–70.CrossRef Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, Flasche S, Clifford S, Pearson CA, Munday JD, et al.The effect of control strategies to reduce social mixing on outcomes of the covid-19 epidemic in wuhan, china: a modelling study. Lancet Public Health. 2020; 5(5):e261–70.CrossRef
12.
go back to reference The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China, 2020. China CDC Wkly. 2020; 2:113.CrossRef The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China, 2020. China CDC Wkly. 2020; 2:113.CrossRef
13.
go back to reference Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-ncov) in wuhan, china. J Med Virol. 2020; 92(4):441–47.CrossRef Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-ncov) in wuhan, china. J Med Virol. 2020; 92(4):441–47.CrossRef
14.
go back to reference Read JM, Lessler J, Riley S, Wang S, Tan LJ, Kwok KO, Guan Y, Jiang CQ, Cummings DA. Social mixing patterns in rural and urban areas of southern China. Proc R Soc B Biol Sci. 2014; 281(1785):20140268.CrossRef Read JM, Lessler J, Riley S, Wang S, Tan LJ, Kwok KO, Guan Y, Jiang CQ, Cummings DA. Social mixing patterns in rural and urban areas of southern China. Proc R Soc B Biol Sci. 2014; 281(1785):20140268.CrossRef
17.
go back to reference Armbruster B, Brandeau ML. Contact tracing to control infectious disease: when enough is enough. Health Care Manag Sci. 2007; 10(4):341–55.CrossRef Armbruster B, Brandeau ML. Contact tracing to control infectious disease: when enough is enough. Health Care Manag Sci. 2007; 10(4):341–55.CrossRef
18.
go back to reference Du L, Wang J, Luo B, et al. Research on disease burden of SARS patients in guangzhou city. Chin J Publich Health - Shenyang. 2007; 23(3):0379. Du L, Wang J, Luo B, et al. Research on disease burden of SARS patients in guangzhou city. Chin J Publich Health - Shenyang. 2007; 23(3):0379.
19.
go back to reference Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, Park SY, Son H. -J., Yu S, Park JW, et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with sars-cov-2 infection in a community treatment center in the republic of korea. JAMA Intern Med. 2020; 180(11):1447–52.CrossRef Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, Park SY, Son H. -J., Yu S, Park JW, et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with sars-cov-2 infection in a community treatment center in the republic of korea. JAMA Intern Med. 2020; 180(11):1447–52.CrossRef
20.
go back to reference Buonanno G, Stabile L, Morawska L. Estimation of airborne viral emission: Quanta emission rate of sars-cov-2 for infection risk assessment. Environ Int. 2020; 141:105794.CrossRef Buonanno G, Stabile L, Morawska L. Estimation of airborne viral emission: Quanta emission rate of sars-cov-2 for infection risk assessment. Environ Int. 2020; 141:105794.CrossRef
21.
go back to reference Bootsma MCJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci. 2007; 104(18):7588–93. https://doi.org/10.1073/pnas.0611071104. http://arxiv.org/abs/https://www.pnas.org/content/104/18/7588.full.pdf.CrossRef Bootsma MCJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci. 2007; 104(18):7588–93. https://​doi.​org/​10.​1073/​pnas.​0611071104.​ http://arxiv.org/abs/https://www.pnas.org/content/104/18/7588.full.pdf.CrossRef
22.
go back to reference Raftery A, Bao L. Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling. Biometrics. 2010; 66(4):1162–73.CrossRef Raftery A, Bao L. Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling. Biometrics. 2010; 66(4):1162–73.CrossRef
23.
go back to reference Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. Nonidentifiability in model calibration and implications for medical decision making. Med Dec Making. 2018; 38(7):810–21.CrossRef Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. Nonidentifiability in model calibration and implications for medical decision making. Med Dec Making. 2018; 38(7):810–21.CrossRef
30.
go back to reference Russell TW, Hellewell J, Jarvis CI, Van Zandvoort K, Abbott S, Ratnayake R, Flasche S, Eggo RM, Edmunds WJ, Kucharski AJ, et al. Estimating the infection and case fatality ratio for coronavirus disease (covid-19) using age-adjusted data from the outbreak on the diamond princess cruise ship, february 2020. Eurosurveillance. 2020; 25(12):2000256.CrossRef Russell TW, Hellewell J, Jarvis CI, Van Zandvoort K, Abbott S, Ratnayake R, Flasche S, Eggo RM, Edmunds WJ, Kucharski AJ, et al. Estimating the infection and case fatality ratio for coronavirus disease (covid-19) using age-adjusted data from the outbreak on the diamond princess cruise ship, february 2020. Eurosurveillance. 2020; 25(12):2000256.CrossRef
33.
go back to reference O’Connor P, Assaker G. Covid-19’s effects on future pro-environmental traveler behavior: an empirical examination using norm activation, economic sacrifices, and risk perception theories. J Sustain Tour. 2021:1–19. O’Connor P, Assaker G. Covid-19’s effects on future pro-environmental traveler behavior: an empirical examination using norm activation, economic sacrifices, and risk perception theories. J Sustain Tour. 2021:1–19.
34.
go back to reference Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-covid features: A 6-month retrospective cohort study of 273,618 survivors of covid-19. PLoS Med. 2021; 18(9):1003773.CrossRef Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-covid features: A 6-month retrospective cohort study of 273,618 survivors of covid-19. PLoS Med. 2021; 18(9):1003773.CrossRef
38.
go back to reference Raimondi F, Novelli L, Ghirardi A, Russo FM, Pellegrini D, Biza R, Trapasso R, Giuliani L, Anelli M, Amoroso M, et al. Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study. BMC Pulm Med. 2021; 21(1):1–11.CrossRef Raimondi F, Novelli L, Ghirardi A, Russo FM, Pellegrini D, Biza R, Trapasso R, Giuliani L, Anelli M, Amoroso M, et al. Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study. BMC Pulm Med. 2021; 21(1):1–11.CrossRef
Metadata
Title
Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study
Authors
Anthony Zhenhuan Zhang
Eva A. Enns
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-12659-2

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue